Sept, 10, 2024 — At the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain, Lunit presented a study on how AI technology can predict immunotherapy response in advanced gastric cancer patients, potentially impacting treatment decisions.

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how artificial intelligence can help tackle the complexities of lung cancer screening and diagnosis.

"The Role of Artificial Intelligence in Lung Cancer Diagnosis and Screening" provides insight into the potential of AI to address some of the most burdensome lung cancer screening and diagnostic challenges.

Sept. 10, 2024 – Landauer recently unveiled a package of updates to its dosimetry account management platform, myLDR. Included in the updates is Signature Suite, a compliance documentation upgrade that reduces the time, risk and effort involved with meeting regulatory requirements by enabling subscribers to leverage a completely digital workflow.

Sept. 11, 2024 — A new study introduced at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung Cancer in San Diego, Calif., shows promising initial results using AI-powered chest X-ray interpretation to detect pulmonary nodules which could develop into early-stage lung cancers long before symptoms appear. The retrospective study demonstrated via interim results, an average diagnostic delay of nearly three years from the first abnormal chest X-ray.

Sept. 9, 2024 — Lunit has announced a collaboration with Roche to integrate Lunit SCOPE PD-L1 22C3 TPS into Roche's navify Digital Pathology platform.

This marks the first deployment of Lunit's AI technology with Roche, supporting pathologists and scientists with enhanced tools for cancer research as part of Roche's initiative to create a collaborative digital pathology ecosystem.

Sep. 09, 2024 – Better image quality, same reading times or faster, increased confidence in diagnosis, reduced time to potential intervention, and potential to divert cases from CT imaging. This is a summary of a study using the Reveal 35C detector in the ICU, to be presented at this year’s American Society of Emergency Radiology (ASER) Meeting that will take place Sept. 11 to 14 in Washington, D.C.

Sept. 5, 2024 — Alba is a new a clinical-grade multimodal co-pilot designed to revolutionize personalized medicine and precision oncology.

Aug. 28, 2024 — Rezolut, LLC recently debuted its latest offering for patients during their annual mammogram, SecondReadAI powered by Lunit. This artificial intelligence (AI) technology provides an additional analysis to detect fine details that could be overlooked by the interpreting physician.   

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of Medicine to investigate advanced magnetic resonance imaging (MRI) protocols and techniques for female-specific diseases and conditions of the pelvis and develop comprehensive educational materials for clinicians. The goal of the project is to elevate women’s pelvic health, filling an important gap in medical research and care.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now